PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9604692-0	1997	The in vitro study on genotoxic activity of adriamycin and bleomycin in cells of mice with different catalase and superoxide dismutase activity.	Bleomycin	59-68	catalase	Mus musculus	101-109	
25844688-8	2015	Bosentan but not imatinib ameliorated superoxide dismutase and catalase activities, which were lowered following bleomycin instillation.	Bleomycin	113-122	catalase	Mus musculus	63-71	
2451525-3	1988	Protection of lung tissue from bleomycin-induced toxicity may occur through both specific metabolic inactivation of bleomycin by the enzyme bleomycin hydrolase, as well as by such non-specific antioxidants as catalase and the glutathione system.	Bleomycin	31-40	catalase	Mus musculus	209-217	
21190578-4	2010	We examined the degree of bleomycin-induced inflammation and fibrosis in the mice with lowered catalase activity.	Bleomycin	26-35	catalase	Mus musculus	95-103	
25026360-10	2014	Catalase (CAT) was increased due to high dose of silymarin (65.7 micromol/min/ml protein) compare with bleomycin treated-mice.	Bleomycin	103-112	catalase	Mus musculus	0-8	
21190578-7	2010	In C57BL/6J mice, catalase activity was suppressed along with downregulation of catalase mRNA in whole lung homogenates after bleomycin administration.	Bleomycin	126-135	catalase	Mus musculus	18-26	
21190578-7	2010	In C57BL/6J mice, catalase activity was suppressed along with downregulation of catalase mRNA in whole lung homogenates after bleomycin administration.	Bleomycin	126-135	catalase	Mus musculus	80-88